TITLE

News Briefs

PUB. DATE
March 2011
SOURCE
American Journal of Health-System Pharmacy;3/1/2011, Vol. 68 Issue 5, p374
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers news briefs pertaining to the pharmacy sector. The Allegra and Allegra-D lines of non prescription fexofenadine containing products have been approved by the Food and Drug Administration (FDA). The Pharmacy Technician Certification Board (PTCB) announced in January that over 40,000 pharmacy technicians have received the credential of Certified Pharmacy Technician. An obituary for editor of the Journal of the Pharmacy Society of Wisconsin, Curtis A. Johnson is presented.
ACCESSION #
58638931

 

Related Articles

  • Oxytrol for Women Now OTC.  // Monthly Prescribing Reference;Mar2013, Vol. 29 Issue 3, pA-13 

    The article informs that U.S. Food & Drug Administration (FDA) has approved drug Oxytrol for women, the first over-the-counter (OTC) treatment for overactive bladder in women.

  • OTC.  // Drug Topics;10/6/2003, Vol. 147 Issue 19, p116 

    Features various over-the-counter drugs approved by the U.S. Food and Drug Administration as of October 2003. PrimaVu Herbal Eye Drops from Prima Vu Health Care; Sierra Medicinals' Dr. Steven Rosenblatt's Starch Blocker.

  • Q & A Future of OTC.  // Drug Store News;3/17/2014, Vol. 36 Issue 3, p22 

    The article presents questions and answers related to over-the-counter (OTC) drugs in the U.S., the progress in making OTCs eligible for the U.S. Food and Drug Administration and the key opportunities for the OTC industry.

  • Sanofi-aventis' Allegra to Go O-T-C.  // MMR;2/7/2011, Vol. 28 Issue 3, p16 

    The article reports about the U.S. Food and Drug Administration's approval of an allergy medication Allegra-D for over-the-counter use.

  • Mevacor's OTC switch draws mixed views.  // Drug Topics;1/24/2005, Vol. 149 Issue 2, p4 

    This article reports on the mixed views concerning the issue of whether the U.S. Food and Drug Administration should approve the lovastatin drug Mevacor from Merck & Co. Inc. as an over-the-counter drug.

  • The Importance of FDA Approval Packages and Briefing Documents in Pharmacy Education. Sasich, Larry D.; Sukkari, Sana R.; Cook, G. Elliott; Tuttle, Donald A. // American Journal of Pharmaceutical Education;Jul2011, Vol. 75 Issue 7, p1 

    A letter to the editor is presented in response to the article that underscores the significance of the U.S. Food and Drug Administration (FDA) approval documents in conducting independent evaluations on the therapeutic values of new drugs.

  • Regulatory Regime.  // U.S. Pharma & Healthcare Report;Q1 2012, Issue 1, p15 

    The article discusses the regulatory regime of the U.S. Food and Drug Administration (FDA). The primary tasks of the FDA include product approvals, labelling and ensuring high manufacturing standards, providing manufacturing establishment licenses and ensuring safety of the blood supply. The...

  • The Case for Leaving the 510(k) Argument Out of a Pleading. O'Reilly, Jim // Products Liability;Summer2013, Vol. 24 Issue 2, p16 

    The article presents a history of the 1976 Medical Device Amendments as a background to the 510(k) regulatory approval process of the U.S. Food and Drug Administration. The author narrates his experience as a drafter in the writing and adopting classification standards for medical devices. It...

  • New products.  // Drug Topics;Sep2010, Vol. 154 Issue 9, p53 

    The article offers news briefs related to over-the-counter (OTC) drugs. The U.S. Food and Drug Administration (FDA) has approved the analgesic Butrans Transdermal System Chill from Purdue Pharma LP. Kamada Ltd. has announced FDA approval of Glassia, a treatment of emphysema. GlaxoSmithKline has...

  • FDA Actions.  // Critical Care Alert;Jan2008 Pharmacology Watch, p2 

    The article reports on the approval of the over-the-counter sales of Zyrtec-D, which is a cetirizine five milligram (mg) plus pseudoephedrine hydrochloride 120 mg, by the U.S. Food and Drug Administration (FDA). It is recommended for adults and children aged 12 years and older. It is also...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics